Which of these withdrawn medications led to the FDA Amendments Act of 2007, establishing stronger post-marketing safety surveillance systems for pharmaceuticals?

In the healthcare industry, product recalls can significantly impact patient safety, company reputation, and market dynamics. Major recalls often lead to substantial changes in industry regulations and practices. Test your knowledge about one of the most consequential pharmaceutical product recalls in recent history that transformed how medical products are monitored post-market.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vioxx (rofecoxib), withdrawn in 2004 after being linked to increased risk of heart attacks and strokes
Fen-Phen (fenfluramine/phentermine), withdrawn in 1997 due to heart valve damage concerns
Baycol (cerivastatin), withdrawn in 2001 after being associated with rhabdomyolysis
Rezulin (troglitazone), withdrawn in 2000 due to severe liver toxicity